Up a level |
2022
Humbert, Marc ORCID: 0000-0003-0703-2892, Kovacs, Gabor, Hoeper, Marius M., Badagliacca, Roberto, Berger, Rolf M. F., Brida, Margarita, Carlsen, Jorn, Coats, Andrew J. S., Escribano-Subias, Pilar, Ferrari, Pisana, Ferreira, Diogenes S., Ghofrani, Hossein Ardeschir, Giannakoulas, George, Kiely, David G., Mayer, Eckhard, Meszaros, Gergely, Nagavci, Blin ORCID: 0000-0002-6626-2842, Olsson, Karen M., Pepke-Zaba, Joanna, Quint, Jennifer K., Radegran, Goran, Simonneau, Gerald, Sitbon, Olivier, Tonia, Thomy, Toshner, Mark, Vachiery, Jean-Luc, Noordegraaf, Anton Vonk, Delcroix, Marion, Rosenkranz, Stephan, Schwerzmann, Markus, Bush, Andy, Abdelhamid, Magdy, Aboyans, Victor, Arbustini, Eloisa, Asteggiano, Riccardo, Barbera, Joan-Albert, Beghetti, Maurice ORCID: 0000-0002-1841-0927, Cikes, Maja, Condliffe, Robin, de Man, Frances, Falk, Volkmar, Fauchier, Laurent, Gaine, Sean, Galie, Nazzareno, Gin-Sing, Wendy, Granton, John, Grunig, Ekkehard, Hassoun, Paul M., Hellemons, Merel, Jaarsma, Tiny, Kjellstrom, Barbro, Klok, Frederikus A., Konradi, Aleksandra, Koskinas, Konstantinos C., Kotecha, Dipak ORCID: 0000-0002-2570-9812, Lang, Irene, Lewis, Basil S., Linhart, Ales, Lip, Gregory Y. H., Lochen, Maja-Lisa, Mathioudakis, Alexander G., Mindham, Richard ORCID: 0000-0003-1116-5284, Moledina, Shahin, Naeije, Robert, Nielsen, Jens Cosedis ORCID: 0000-0001-9414-1653, Olschewski, Horst, Opitz, Isabelle ORCID: 0000-0001-5900-9040, Petersen, Steffen E., Prescott, Eva, Rakisheva, Amina, Reis, Abilio, Ristic, Arsen D., Roche, Nicolas, Rodrigues, Rita, Selton-Suty, Christine, Souza, Rogerio, Swift, Andrew J., Touyz, Rhian M., Ulrich, Silvia, Wilkins, Martin R. and Wort, Stephen John (2022). 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG). Eur. Heart J., 43 (38). S. 3618 - 3732. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
2020
Bergmark, Brian A., O'Donoghue, Michelle L., Murphy, Sabina A., Kuder, Julia F., Ezhov, Marat V., Ceska, Richard, Gouni-Berthold, Ioanna, Jensen, Henrik K., Tokgozoglu, S. Lale, Mach, Francois, Huber, Kurt, Gaciong, Zbigniew, Lewis, Basil S., Schiele, Francois, Jukema, J. Wouter, Pedersen, Terje R., Giugliano, Robert P. and Sabatine, Marc S. (2020). An Exploratory Analysis of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition and Aortic Stenosis in the FOURIER Trial. JAMA Cardiol., 5 (6). S. 709 - 714. CHICAGO: AMER MEDICAL ASSOC. ISSN 2380-6591
2017
Sabatine, Marc S., Leiter, Lawrence A., Wiviott, Stephen D., Giugliano, Robert P., Deedwania, Prakash, De Ferrari, Gaetano M., Murphy, Sabina A., Kuder, Julia F., Gouni-Berthold, Ioanna, Lewis, Basil S., Handelsman, Yehuda, Pineda, Armando Lira, Honarpour, Narimon, Keech, Anthony C., Sever, Peter S. and Pedersen, Terje R. (2017). Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial. Lancet Diabetes Endocrinol., 5 (12). S. 941 - 951. NEW YORK: ELSEVIER SCIENCE INC. ISSN 2213-8587